Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H BLUM

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Oncology|December 1, 1984
Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinomaA M Schmidt, R H Blum, M Clayton, et al.
Cancer Treatment Reports|March 1, 1981
Phase I trial of combination therapy with PALA and 5-FUM W Meshad, T J Ervin, D Kufe, et al.
Cancer|October 15, 1980
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD)R H Blum, J M Corson, R E Wilson, et al.
Cancer|December 1, 1977
Adriamycin plus alkylating agents in the treatment of metastatic breast cancerJ J Lokich, A T Skarin, R J Mayer, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factorA Chachoua, R Oratz, R Hoogmoed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Investigational New Drugs|January 1, 1986
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trialH S Hochster, M D Green, R H Blum, et al.
Cancer Treatment Reports|October 1, 1980
Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA)T J Ervin, R H Blum, M W Meshad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684J M Kirkwood, M H Strawderman, M S Ernstoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2023
Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684J M Kirkwood, M H Strawderman, M S Ernstoff, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Oncology|December 1, 1984
Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinomaA M Schmidt, R H Blum, M Clayton, et al.
Cancer Treatment Reports|March 1, 1981
Phase I trial of combination therapy with PALA and 5-FUM W Meshad, T J Ervin, D Kufe, et al.
Cancer|October 15, 1980
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD)R H Blum, J M Corson, R E Wilson, et al.
Cancer|December 1, 1977
Adriamycin plus alkylating agents in the treatment of metastatic breast cancerJ J Lokich, A T Skarin, R J Mayer, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factorA Chachoua, R Oratz, R Hoogmoed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Investigational New Drugs|January 1, 1986
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trialH S Hochster, M D Green, R H Blum, et al.
Cancer Treatment Reports|October 1, 1980
Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA)T J Ervin, R H Blum, M W Meshad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684J M Kirkwood, M H Strawderman, M S Ernstoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2023
Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684J M Kirkwood, M H Strawderman, M S Ernstoff, et al.
Pageof 5